Osteopathic Treatment and Deep Vein Thrombosis (DVT)

NCT02205294 — Not applicable, Completed, 30 participants, Nova Scotia Health Authority

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

The Effect of Osteopathic Treatment in Acute Proximal Leg Deep Vein Thrombosis (DVT) to Reduce Pain and Swelling

Registry	NCT02205294
Status	Completed
Phase	Not applicable
Study type	Interventional; randomized, parallel, masking: single, treatment
Enrollment	30 (Actual)
Sponsor	Nova Scotia Health Authority (Other)
Conditions	Deep Vein Thrombosis (DVT)
Interventions	Osteopathic Treatment (Other)
Dates	start 2014-11-06, primary completion 2019-04-04, completion 2019-04-04, first posted 2014-07-31, last updated 2023-06-15
Locations	1 site in Canada

-Summary

Osteopathic treatment will provide:

1. A significant reduction of pain and swelling of the affected DVT leg
2. An increase in the quality of life (QOL) for individuals with DVT of the leg
3. Improved signs and symptoms of the post thrombotic syndrome of the affected DVT leg

Expand all sections · Collapse all

+Detailed description

Thousands of individuals are affected by deep vein thrombosis (DVT) every year. Medical treatment is aimed at preventing extension and recurrence of the blood clot (DVT) through the use of anticoagulation medication. Compression stockings may be added for reduction of pain and swelling, but this therapy remains controversial amongst physicians. To date, there is limited manual therapies available for individuals affected with DVT. Regular medical treatment, anticoagulation medication, along with osteopathic treatment may offer these individuals improved control of the symptoms associated with DVT. In the long term osteopathic treatment may provide an increase in the quality of life (QOL) and improve the signs and symptoms associated with the post-thrombotic syndrome (PTS), which can be burdensome for both the individual and the health care system. Offering an effective add on treatment could provide individuals and the medical system with an additional means of treatment for the symptoms of DVT and also for the prevention of development of PTS.

+Arms and interventions

Arm	Type	Interventions	Description
Assessment Only	No intervention		Subjects will have an osteopathic assessment to determine areas of tension in specific areas of the body. These areas include: the thoracic diaphragm, the heart and pericardium, the iliac fascia, the femoral sheath, the sartorius muscle, the pelvic diaphragm and the interosseous membrane (IM) of the lower extremity
Assessment and Treatment	Active comparator	Other: Osteopathic Treatment	Subjects will have an osteopathic assessment to determine areas of tension in specific areas of the body. These areas of tension will receive osteopathic treatment, using myofascial release techniques. These areas include: the thoracic diaphragm, the heart and pericardium, the iliac fascia, the femoral sheath, the sartorius muscle, the pelvic diaphragm and the interosseous membrane (IM) of the lower extremity

Osteopathic Treatment (Other): The osteopathic treatment will be a gentle hands treatment using myofascial release techniques.

+Outcome measures

Primary outcomes

Swelling [1 month pre and post testing and 2 months]: Swelling will be measured using a tension-controlled tape measure at the initial study visit, one month after diagnosis of the subject's DVT and then again at 2 months after diagnosis.

Secondary outcomes

Leg Pain [1 month pre and post testing and 2 months]: Leg Pain will be measured using the visual analogue scale (VAS), at the initial study visit(1 month after diagnosis of the DVT) pre and post assessment or assessment plus treatment. Pain will be evaluated again at the 2 month visit post answering questionnaires and lying supine for 10 minutes.

Other outcomes

Quality of LIfe (QOL) [1 month and 2 months]: Veines QOL/Sym Questionnaire will be completed by all participants at both study visits to determine if there have been any changes.
Assessment for Post Thrombotic Syndrome (PTS) [1 month and 2 months]: The Villalta scale will be used to assess subjects for signs and symptoms of the post-thrombotic syndrome at both study visits.

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* 18 years of age and older
* first episode of symptomatic objectively confirmed proximal leg DVT without pulmonary embolism
* 1 month of appropriate anticoagulation treatment
* therapeutic level of anticoagulation (ie: Warfarin, INR- 2.0-3.0)

Exclusion Criteria:

* > 1 month + 7 days of anticoagulation
* history of previously confirmed proximal or distal leg DVT
* medically unstable individuals requiring hospitalization
* history of peripheral vascular disease (PVD)
* injury of affected leg (trauma within the last 6 months or leg currently casted)
* history of previous stroke
* uncontrolled hypertension
* renal failure requiring hemodialysis or peritoneal dialysis
* diagnosis of cancer in the last five years or currently receiving treatment for cancer
* open heart or vascular surgery in the last year
* any neurological condition (ie: MS, ALS, Parkinsons, etc)
* currently pregnant
* geographic inaccessibility
* unable to provide informed consent

+Locations (1)

Facility	City	Country	Status
QEll Health Sciences Centre	Halifax, Nova Scotia	Canada

+Investigators

Darlene D MacLeod, BscN DOMP, Principal investigator, Nova Scotia Health Authority

My Notes

Public

To Read Reading Read